Related Experiment Video

Updated: Sep 20, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Natural killer T cells in patients with prostatic carcinoma

B Schwemmer1

  • 1Munich, Germany. BSchwe7133@aol.com

Urologia Internationalis
|August 2, 2003
PubMed

Insights

Natural killer T (NKT) cells may play a role in prostate cancer immunotherapy. Lower NKT cell levels were observed in patients with rising PSA, suggesting a regulatory function in prostate carcinoma.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Natural killer T (NKT) cells are emerging as key effector cells in novel immunotherapy strategies.
  • NKT cells possess characteristics of both T cells and natural killer cells, are CD1d-dependent, and respond to alpha-galactosylceramide.
  • Prostate carcinoma research is exploring new avenues for treatment and understanding disease progression.

Purpose of the Study:

  • To investigate the levels of NKT cells in patients with prostate carcinoma.
  • To examine the relationship between NKT cell levels and disease progression markers, specifically Prostate-Specific Antigen (PSA).
  • To assess the correlation between NKT cells and CD8+ cells in prostate cancer patients.

Main Methods:

  • Peripheral blood samples were collected from 54 patients diagnosed with prostatic carcinoma.
  • NKT cell counts were measured alongside CD8+ cells and natural killer cells.
  • Statistical analysis was performed to compare cell levels between patient groups and to determine correlations.

Main Results:

  • Patients with stable PSA levels (androgen withdrawal) exhibited significantly higher NKT cell counts (211.8 cells/microl) compared to those with rising PSA levels (27.0 cells/microl).
  • A similar, though less distinct, difference was observed for CD8+ cells between the two groups.
  • A strong positive correlation (r = 0.83) was identified between NKT cell and CD8+ cell levels across all patients.

Conclusions:

  • NKT cell levels are significantly lower in prostate cancer patients with progressive disease (rising PSA).
  • These findings suggest a potentially important regulatory role for NKT cells in the context of prostate carcinoma.
  • NKT cells may represent a viable target for future immunotherapeutic interventions in prostate cancer.

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...